ESCI期刊Cardiovascular Revascularization Medicine 2024/2025影响因子:1.678 (CARDIOVASC REVASCULA) (1553-8389). (CARDIAC & CARD

显示全部楼层 · 发表于 2025-3-27 01:59:21

Submitted on: 01 June 2015. Revised on: 16 September 2015. Accepted on: 09 November 2015. ___________________Cardiovascular Revascularization Medicine

显示全部楼层 · 发表于 2025-3-27 06:33:22

Submitted on: 08 June 2022. Revised on: 17 August 2022. Accepted on: 01 October 2022. ___________________Cardiovascular Revascularization Medicine

显示全部楼层 · 发表于 2025-3-27 12:17:09

Submitted on: 08 October 2010. Revised on: 31 December 2010. Accepted on: 17 January 2011. ___________________Cardiovascular Revascularization Medicine

显示全部楼层 · 发表于 2025-3-27 17:29:08

Submitted on: 26 June 2000. Revised on: 02 October 2000. Accepted on: 15 October 2000. ___________________Cardiovascular Revascularization Medicine

显示全部楼层 · 发表于 2025-3-27 18:37:22

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-26 20:51
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Cardiovascular Revascularization Medicine 2024/2025影响因子:1.678 (CARDIOVASC REVASCULA) (1553-8389). (CARDIAC & CARD

浏览过的版块